Skip to main content
SpringerLink
Log in

Physicians' knowledge of biosimilars "insufficient"

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. a group of physicians, innovators and patients working together to ensure that patient safety is the top priority of biosimilars policy discussions

  2. European Association of BioIndustries

Reference

  • Alliance for Safe Biologic Medicines. Pan-European survey calls for a shift in policy for biosimilars. Media Release : 18 Mar 2014. Available from: URL: http://safebiologics.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Physicians' knowledge of biosimilars "insufficient". Reactions Weekly 1494, 1 (2014). https://doi.org/10.1007/s40278-014-9649-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-9649-7

Search

Navigation